Fig. 1

Escitalopram group made significantly more errors in the EDS, compared with the placebo group, following false discovery rate control of q < 0.15 with the Benjamini–Hochberg procedure, as denoted with an asterisk

Escitalopram group made significantly more errors in the EDS, compared with the placebo group, following false discovery rate control of q < 0.15 with the Benjamini–Hochberg procedure, as denoted with an asterisk